🔗 Permalink

Inventor profile of:

Anders ENEROTH

City:

Huddinge

Country:

Sweden

Published Applications:

Last publication date:

2023-11-30

Top Assignees for applications by Anders ENEROTH

The entities that hold a legal rights for patent applications filed by inventor ENEROTH Anders:

Medivir AB 5 Stockholm, Sweden
MEDIVIR AB 2 Huddinge, Sweden
Medivir Aktiebolag 2 Huddinge, Sweden

Recent patent applications by ENEROTH Anders

Anders ENEROTH from Huddinge, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-30

US20230382931A1

Chemistry; metallurgy

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

#2 | 2023-04-20

US20230117570A1

Chemistry; metallurgy

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

#3 | 2021-02-25

US20210054008A1

Chemistry; metallurgy

Dioxolane analogues of uridine for the treatment of cancer

#4 | 2020-07-30

US20200239502A1

Chemistry; metallurgy

Dioxolane analogues of uridine for the treatment of cancer

#5 | 2020-01-09

US20200009166A1

Human necessities

Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancer

#6 | 2019-12-26

US20190389890A1

Chemistry; metallurgy

Dioxolane analogues of uridine for the treatment of cancer

#7 | 2019-04-04

US20190100541A1

Chemistry; metallurgy

Dioxolane analogues of uridine for the treatment of cancer

#8 | 2019-03-28

US20190091246A1

Human necessities

Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabine

#9 | 2017-09-21

US20170267705A1

Chemistry; metallurgy

Dioxolane analogues of cytidine for the treatment of cancer

#10 | 2014-03-06

US20140066398A1

Chemistry; metallurgy

HCV POLYMERASE INHIBITORS

#11 | 2013-06-06

US20130143835A1

Chemistry; metallurgy

HCV Polymerase Inhibitors

InventorID:

275940 ⎘